Back to search
FDAFDA · Food and drugs·Recall number Z-0963-2019

Hermes NC PTA Balloon Dilatation Catheter The balloon dilatation catheter is intended to dilate stenoses in the iliac, femoral, iliofemoral, popliteal, infrapopliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also indicated for stent dilatation post-deployment in the peripheral vasculature.

Published March 6, 2019 · Recall initiated: December 14, 2018

Summary

FDA records medical device Class II recall Z-0963-2019, published March 6, 2019 and initiated December 14, 2018. Recalling firm: BrosMed Medical Co.,Ltd.; Status: Terminated; Reported quantity: 400; Lot: Lot #'s: F1800580, F1800582, F1800583, F1800585, F1800581, F1800584, F1804186, F1804187, F1804188, and F1804189. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect (higher) Rated Burst Pressure information printed on label.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BrosMed Medical Co.,Ltd.
Distributor
US Distribution to MO.
Lot
Lot #'s: F1800580, F1800582, F1800583, F1800585, F1800581, F1800584, F1804186, F1804187, F1804188, and F1804189.
Risk classification
Class II
Area (FDA)
device
Country
China

Related recalls

Questions about this recall

Was Hermes NC PTA Balloon Dilatation Catheter The balloon dilatation catheter is intended to dilate stenoses in the iliac, femoral, iliofemoral, popliteal, infrapopliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also indicated for stent dilatation post-deployment in the peripheral vasculature. recalled?

Yes. FDA published recall Z-0963-2019 on March 6, 2019. Reported hazard: Incorrect (higher) Rated Burst Pressure information printed on label.

What should I do if I have this product?

Voluntary: Firm initiated · Letter